Insomnia in neurological diseases

This guideline explores the links between insomnia and neurological diseases such as stroke, Parkinson's disease, multiple sclerosis, and dementia. Insomnia, characterized by difficulty falling or staying asleep, often worsens cognitive function and quality of life in these conditions. Underlying causes include neurodegenerative changes, motor symptoms, and medications. Treatments like cognitive-behavioral therapy for insomnia (CBTi), melatonin, and light therapy have shown promise. Addressing insomnia early can help improve cognition and slow disease progression in conditions like Alzheimer's. Recommendations stress combining lifestyle modifications with targeted therapies to optimize brain health.

To improve sleep and brain health, establish regular sleep habits, manage light exposure, and consider CBTi for persistent insomnia. Incorporate melatonin or light therapy if recommended by a physician, especially in cases involving neurological conditions. Early intervention in insomnia can protect cognitive function, but effectiveness depends on the specific neurological disease and individual circumstances.